Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionTruvestments Capital Llc
Latest Disclosed Ownership28 shares
Latest Disclosed Value $ 3,689
Truvestments Capital Llc reports 46.15% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 13, 2026 - Truvestments Capital Llc filed a 13F-HR form disclosing ownership of 28 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $3,689 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 52 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -46.15% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 28 -24 -46.15 4 -57.14 0.0007
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 52 -22 -29.73 7 -30.00 0.0013
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 74 -225 -75.25 10 -72.97 0.0019
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 299 0 0.00 38 12.12 0.0075
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 299 -259 -46.42 33 -56.58 0.0072
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 558 14 2.57 76 22.58 0.0196
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 544 544 63 0.0168
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -566 -100.00 0 -100.00
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 566 298 111.19 78 122.86 0.0300
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 268 0 0.00 35 16.67 0.0159
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 268 0 0.00 30 20.00 0.0157
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 268 0 0.00 25 -7.41 0.0126
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 268 0 0.00 27 -15.62 0.0145
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 268 -845 -75.92 32 -72.88 0.0181
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,113 0 0.00 118 9.26 0.0744
2022-08-09 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,113 1,113 108 0.0632
2022-05-02 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,226 -100.00 0 -100.00
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,226 195 18.91 104 5.05 0.0522
2021-10-29 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,031 34 3.41 99 2.06 0.0546
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 997 224 28.98 97 29.33 0.0532
2021-05-18 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 773 495 178.06 75 188.46 0.0424
2021-02-17 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 278 278 26 0.0180
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -80 -100.00 0 -100.00
2020-08-06 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 80 11 15.94 9 80.00 0.0092
2020-05-07 2020-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 69 69 5 0.0064
2020-01-29 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -38 -100.00 0 -100.00
2019-10-10 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 38 38 3 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.